Faiz Kermani is a Senior Account Manager at Health interactions, USA.
The mechanism of action (MOA) animation is becoming an increasingly popular way to convey important information about a drug, but pharma companies are being slow to realise its potential. Faiz Kermani reports.
Supply Chain Strategy: Managing risk and opportunity in a changing global landscape
Sponsored By PricewaterhouseCoopers LLP Optimizing the Multi-Sponsor REMS Experience (Risk Evaluation & Mitigation Strategies)
Sponsored By PricewaterhouseCoopers LLP Effective Resource Planning: Reducing Clinical Project Risk and Operating Cost
Sponsored By ClearTrial